R&D teams across the world face the same challenge every week: a mind-boggling awry of investment opportunities emerging because of new scientific discoveries, technologies, and artificial intelligence.
Case study 1
“We are conducting a scientific due diligence of an asset that’s available for purchase in the next six weeks. We need to speak with people with experience of this technology in this area.”
Case study 2
“We have no experience, and therefore no corporate wisdom, in this therapeutic condition. We would like to talk to people who have experience of working with regulators and reimbursement agencies in this space.”
Case study 3
“We have just acquired a company and there are assets in their pipeline in areas that we have no experience in. We need to find experts in these areas who can give us an independent view on their attractiveness and potential.”
In a handful of weeks business development teams need to engage with scientific and medical leaders who can examine the technology; conceptualise how it might fit into treatment plans; and form opinions on its likely adoption.
Where are the experts with contextual intelligence, credibility, and wisdom in a specific therapeutic condition to be found?
· It’s not just a case of finding those with the highest number of published papers, or involvement in clinical trials.
· It’s certainly more than adding up the sum of people liking, re-posting, or commenting on their social media posts.
That’s why we have developed an online platform called Thecosystems – it is a curated view of a single therapeutic ecosystem. It contains the movers and shakers: those holding positions of authority and influence in a therapeutic area – think guideline authors, and those whose opinions regulators and policy makers consult.
Learn more about how we can help throughout the R&D Lifecycle here →